When to restart Eliquis (apixaban) after a colonoscopy?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: September 16, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Restarting Eliquis (Apixaban) After Colonoscopy

Eliquis (apixaban) should be restarted up to 48 hours after colonoscopy, depending on the bleeding risk from the procedure and the patient's thrombotic risk. 1

Risk Stratification

Procedure-Related Bleeding Risk

  • Low-risk procedures (bleeding risk <1%):

    • Diagnostic colonoscopy with or without biopsies
    • Resume Eliquis the same day once adequate hemostasis is achieved
  • High-risk procedures (bleeding risk >1%):

    • Colonoscopy with polypectomy
    • Endoscopic mucosal resection (EMR)
    • Endoscopic submucosal dissection (ESD)
    • Resume Eliquis 24-48 hours after the procedure

Patient Thrombotic Risk

  • High thrombotic risk:

    • Mechanical mitral valve
    • Prosthetic valve with prior thromboembolism
    • Recent (<3 months) venous thromboembolism
    • Atrial fibrillation with prior stroke or multiple risk factors
    • Resume Eliquis earlier (24 hours post-procedure)
  • Low thrombotic risk:

    • Non-valvular atrial fibrillation with lower CHADS₂ score
    • 3 months after venous thromboembolism

    • Can delay Eliquis resumption to 48 hours post-procedure

Specific Timing Recommendations

  1. For diagnostic colonoscopy without intervention:

    • Resume Eliquis the same day once adequate hemostasis is achieved 1
  2. For colonoscopy with polypectomy or other high-risk intervention:

    • High thrombotic risk patients: Resume Eliquis 24 hours after procedure 1, 2
    • Low thrombotic risk patients: Resume Eliquis 48 hours after procedure 1, 2
  3. For large or complex polypectomies (polyps ≥20mm or piecemeal resection):

    • Consider delaying Eliquis resumption for 48-72 hours 2

Important Considerations

  • The risk of post-polypectomy bleeding can be as high as 0.8-23% in anticoagulated patients compared to 0.07-1.7% in non-anticoagulated patients 2

  • Unlike warfarin, Eliquis reaches therapeutic anticoagulation levels within 2-4 hours after administration, so timing of resumption is critical 3

  • No bridging anticoagulation is required when restarting Eliquis 1, 2

  • The FDA label for Eliquis states that it "should be restarted after surgical or other procedures as soon as adequate hemostasis has been established" 3

  • A 2022 study showed that most patients achieve clinically insignificant levels of apixaban (≤30 ng/mL) within 48 hours of discontinuation 4

Practical Algorithm

  1. Assess procedure outcome:

    • Was there complete hemostasis?
    • Were there any complications during the procedure?
    • Size and number of polyps removed?
  2. Evaluate patient's thrombotic risk:

    • Review indication for anticoagulation
    • Consider comorbidities and risk factors
  3. Determine timing:

    • Uncomplicated diagnostic procedure → Resume same day
    • Standard polypectomy with low thrombotic risk → Resume at 48 hours
    • Standard polypectomy with high thrombotic risk → Resume at 24 hours
    • Complex polypectomy → Consider delaying to 48-72 hours
  4. Monitor for complications:

    • Educate patient about signs of bleeding
    • Schedule appropriate follow-up

By following this evidence-based approach to restarting Eliquis after colonoscopy, you can balance the risks of thromboembolism against the risks of post-procedural bleeding.

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Peri-Procedural Anticoagulation Management for Colonoscopy

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.